P21
Also known as: P021 · CNTF-derived peptide
A neurogenic peptide derived from CNTF that promotes hippocampal neurogenesis and clears amyloid plaques, targeting Alzheimer's and TBI recovery.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~2–4 hours
500–1000 mcg
Subcutaneous injection
Mechanism of Action
Mimics CNTF neurotrophic activity to stimulate neural stem cell differentiation while inhibiting tau hyperphosphorylation and amyloid aggregation.
Key Research Areas
Frequently Asked Questions
What is P21?▾
How does P21 work?▾
What is the recommended dosage for P21?▾
What is the half-life of P21?▾
Is P21 FDA approved?▾
Research Disclaimer
The information provided about P21 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.